Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronJuan Manuel Carreño, Florian Krammer, Zain Khalil et al.|Nature|2021Cited by 531
SARS-CoV-2 spike E484K mutation reduces antibody neutralisationSonia Jangra, Michael Schotsaert, Kayla T. Russo et al.|The Lancet Microbe|2021Cited by 435
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myelomaOliver Van Oekelen, Samir Parekh, Ajai Chari et al.|Cancer Cell|2021Cited by 216
Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune seraRaveen Rathnasinghe, Michael Schotsaert, Adolfo Garcı́a-Sastre et al.|Nature Communications|2022Cited by 41